在心脏起器腔中出现的恶性新生体:系统性审查
Francisco Cezar Aquino de Moraes1, Lucca Dal Moro2, Fernando Rocha Pessoa2
1Oncology Research Center, University Hospital João de Barros Barreto, Belém 66073-005, PA, Brazil.
罕见的心脏起器口袋瘤影响老年男性,化疗和放射治疗是常见的治疗方法. 对于患有心脏起器的患者来说,对这些瘤的常规评估至关重要.
科学领域:
- 在瘤学瘤学.
- 心脏病学 心脏病学
- 医疗器械 医疗器械
背景情况:
- 癌症涉及异常的细胞增殖.
- 心脏起器口袋是瘤的罕见地点.
- 了解这些瘤对于患者管理至关重要.
研究的目的:
- 评估心脏起器口袋瘤的临床结果,治疗和预后.
- 审查这些罕见瘤的个性化管理策略.
- 综合从案例报告和系列中得出的发现.
主要方法:
- 对案例报告和案例系列进行系统审查.
- 在PubMed/Medline,Science Direct,Cochrane Central,LILACS和Scielo数据库中进行了搜索.
- 分析了患者的人口统计,瘤特征和治疗方式.
主要成果:
- 受影响的患者平均年龄为72.9岁,主要是男性 (76.9%).
- 新生体在植入后平均4.4年后发展; 医药公司的设备和组成是最常见的.
- 化疗和放射治疗是最常见的治疗方法 (每种为38.4%);46.1%的病例导致死亡,而30.7%的病例治愈.
结论:
- 心脏起器口袋瘤是一种罕见但严重的并发症.
- 治疗方法包括化疗,放射治疗和手术.
- 建议在心脏起器植入部位进行恶性瘤的常规查,以监测患者.
更多相关视频
08:52Generation of Murine Cardiac Pacemaker Cell Aggregates Based on ES-Cell-Programming in Combination with Myh6-Promoter-Selection
Published on: February 17, 2015
14:24Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
相关概念视频
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Specialized Characteristics of Cardiac Muscles
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy...
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
